Skip to content
naulon

Not checkedNot checked for notices yet.

Progress of NRF2 Signaling Pathway in Promoting Proliferation of Non-small Cell Lung Cancer

Yixuan FANG, Xinru ZOU, Shuning HU and 1 more

Chinese Journal of Lung Cancer · 2022

doi:10.3779/j.issn.1009-3419.2022.102.37 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

The morbidity and mortality of lung cancer ranks among the top cancers in the world. Non-small cell lung cancer (NSCLC) is the main pathological type of lung cancer, with limited treatment options and poor prognosis. The nuclear factor E2-related factor 2 (NRF2) signaling pathway is highly mutated and activated in NSCLC, and promotes the malignant progression of lung cancer through various mechanisms. NRF2-targeted therapy will provide new treatment strategies for patients with NSCLC. This article will review the basic structure and response pathways of the NRF2 pathway, the mechanism of NRF2 regulating lung cancer cell proliferation, and the research and development progress of NRF2 inhibitors.

Abstract licence: CC BY

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.